Performance of a directâ  detection active matrix flat panel dosimeter (AMFPD) for IMRT measurements by Chen, Yu et al.
Performance of a direct-detection active matrix flat panel dosimeter
„AMFPD… for IMRT measurements
Yu Chen,a Jean M. Moran, Donald A. Roberts, Youcef El-Mohri,
Larry E. Antonuk, and Benedick A. Fraass
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109
Received 10 May 2007; revised 27 September 2007; accepted for publication 17 October 2007;
published 28 November 2007
The dosimetric performance of a direct-detection active matrix flat panel dosimeter AMFPD is
reported for intensity modulated radiation therapy IMRT measurements. The AMFPD consists of
a-Si:H photodiodes and thin-film transistors deposited on a glass substrate with no overlying
scintillator screen or metal plate. The device is operated at 0.8 frames per second in a continuous
acquisition or fluoroscopic mode. The effect of the applied bias voltage across the photodiodes on
the response of the AMFPD was evaluated because this parameter affects dark signal, lag contri-
butions, and pixel sensitivity. In addition, the AMPFD response was evaluated as a function of dose,
dose rate, and energy, for static fields at 10 cm depth. In continuous acquisition mode, the AMFPD
maintained a linear dose response r20.99999 up to at least 1040 cGy. In order to obtain reliable
integrated dose results for IMRT fields, the effects of lag on the radiation signal were minimized by
operating the system at the highest frame rate and at an appropriate reverse bias voltage. Segmental
MLC and dynamic MLC IMRT fields were measured with the AMFPD, and the results were
compared to film, using standard methods for reliable film dosimetry. Both AMFPD and film
measurements were independently converted to dose in cGy.  and  values were calculated as
indices of agreement. The results from the AMFPD were in excellent agreement with those from
film. When 2% of Dmax and 2 mm of distance to agreement were used as the criteria, 98% of the
region of interest defined as the region where dose is greater than 5% of Dmax satisfied 1 on
average across the cases that were tested. © 2007 American Association of Physicists in Medicine.
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Intensity modulated radiation therapy quality assurance
IMRT QA is performed to ensure that the intended treat-
ment fields obtained from the treatment planning system are
correctly transferred to the treatment delivery system and
accurately delivered when compared with calculations in a
phantom geometry. Several methods of IMRT plan verifica-
tion are used in clinical practice.1 Measurement-based veri-
fication often includes dose verification of the entire treat-
ment plan delivery with an ionization chamber treated at the
planned gantry and collimator positions plus additional two-
dimensional dose verification of individual IMRT fields at a
standard depth, using a perpendicular gantry angle. The two-
dimensional measurements can be made with film or detector
arrays of diodes or ionization chambers.2,3 Due to the wide-
spread availability of amorphous silicon a-Si:H electronic
portal imaging devices EPIDs for patient imaging, the use
of EPIDs for IMRT QA has also been investigated.4–6
In a typical a-Si:H flat panel imaging device with active
matrix addressing using thin-film transistors TFTs, an x-ray
converter consisting of a copper plate and a phosphor scin-
tillator is positioned on the top of the a-Si:H circuits. The
scintillator converts x rays and electrons emerging from the
copper plate into optical photons, which are sensed by a
photodiode located at every pixel. The x-ray conversion lay-
4911 Med. Phys. 34 „12…, December 2007 0094-2405/2007/34„ers are thick enough to produce a detectable change in the
energy fluence of the incident radiation to the photodiode
detectors at the pixels. Although the x-ray converter is used
to improve the x-ray detection efficiency of the imager, it has
a significantly different dose response from that of water-
equivalent materials, which makes the relationship between
the portal dose signal produced by the a-Si:H photodiodes
and the water-equivalent dose more complicated. To address
this constraint, a device employing direct detection of inci-
dent radiation was developed for dosimetric measurements,7
based on an a-Si:H panel like that of a conventional flat
panel imager, but without the x-ray converter. An initial
prototype active matrix flat panel dosimeter AMFPD was
assembled and characterized for its stability, dose response,
dose rate dependence, and energy dependence for a range of
situations, including IMRT field measurements in radio-
graphic mode.8 In this operating mode, all the signal was
integrated on the detector, and the entire array of pixels was
read out after the radiation was completely delivered. Excel-
lent long-term stability of dose response less than 1.5%
variation over a year and good dosimetric agreement be-
tween the AMFPD and film at low doses were reported.
However, dark current and charge trapping led to significant
artifacts in dose images for high dose dosimetry measure-
ments when the AMFPD was operated in radiographic mode.
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4912 Chen et al.: Performance of AMFPD for IMRT dosimetry 4912In the present study, we operate the AMFPD in fluoro-
scopic mode, motivated by the need to understand: 1 The
relationship between the dependence of dark current on
charge accumulated in the photodiode and the dependence of
a dose image on how the radiation is delivered delivery-
history dependence, and 2 the relationship between bias
voltage and pixel sensitivity. In this article, the linearity of
the dose response, the effect of dark current in the photodi-
ode on the accuracy of dosimetric measurements, and the
determination of two-dimensional dose distributions for
IMRT fields are reported. More than 20 IMRT fields were
measured, encompassing dynamic MLC DMLC and seg-
mental MLC SMLC delivery methods, 11 cm2 and 0.5
0.5 cm2 beamlets, and a wide range of doses for IMRT
fields for prostate, head and neck, and partial breast
irradiation.
II. METHOD AND MATERIALS
II.A. The acquisition system
The AMFPD system consists of a flat panel detector and a
control computer. The detector comprised a 2626 cm2
a-Si:H array,9 data transfer electronics, and a power supply.
The control computer sends instructions to the detector and
stores the acquired images. The array consists of 512512
pixels at a pixel pitch of 508 m—with each pixel incorpo-
rating a photodiode that serves to sense the x-ray signal.
Each photodiode is coupled to a TFT. These TFTs act as
switches that are controlled by the acquisition electronics to
capture and then read out the charge stored in the
photodiode—one row of pixels at a time. The gates of the
TFTs along the same row are connected to a shared gate line,
and the drains of the TFTs along the same column are con-
nected to a shared data line. The photodiodes and TFTs,
along with the gate and data lines, are deposited on an
1 mm thick glass substrate. There is no additional x-ray
converter, such as a metal plate or a scintillator, covering the
surface of the photodiodes. The surface of the detector array
is placed at a desired depth in a solid water phantom.
II.B. Operating mode considerations
During irradiation, the signal information extracted from
an array pixel contains a dark signal component unrelated to
the radiation. In order to estimate this component, dark im-
age frames are read out in the absence of radiation. The dark
signal originates from the accumulation of dark current over
a frame time Tframe. The frame time is the interval between
two consecutive readouts of the same row of pixels. The dark
current largely corresponds to leakage current generated in
the reverse-biased photodiode. It results from thermal exci-
tation of the photodiode and depends on the magnitude of the
electric field due to the applied bias voltage Vbias, as illus-
trated in Fig. 1. When the TFT is nonconducting, the electric
field across the photodiode gradually decreases due to the
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or radiation interactions. In general, the dark current is not
constant due to the decrease of the electric field across the
photodiode. On the other hand, pixel sensitivity, i.e., the
amount of charge per unit dose due to radiation, also depends
on the strength of the electric field across the photodiode
Sec. III A, and how it varies during irradiation. In general,
pixel sensitivity and dark current depend on the electric field
and thus are dependent on the total charge generated by the
radiation and the dark current. As charge accumulates during
irradiation, the electric field gradually decreases leading to
reduced dark current and reduced pixel sensitivity. The
charge originating from radiation in a time Tframe is Qrad
=Q−0TframeIdarktdt, where Q is the total charge and Idarkt
is the dark current. In the case of radiographic mode where
the irradiation time can last for tens of seconds, the charge
accumulated due to the dark current can be significantly dif-
ferent from that without radiation. Therefore, a correction
based on the subtraction of a dark image acquired in the
absence of radiation may be inaccurate and can lead to a
dependence on the delivery-history of the resulting corrected
image.
To illustrate this problem, Fig. 2 shows how the dark cur-
rent may decrease during a period corresponding to the
frame time Tframe due to a decrease in the electric field. Since
this decrease is hard to quantify due to its dependence on
many factors, including the manner in which the radiation is
delivered, it is difficult to accurately determine the dark sig-
nal contribution during Tframe. The removal of dark signal
from the total radiation signal has thus far been performed by
simply assuming a constant dark charge obtained in the ab-
sence of radiation. As illustrated in Fig. 2, the error from
subtracting a constant dark charge during a frame time Tframe
FIG. 1. Pixel dark signal in ADC units as a function of the applied bias
voltage across the photodiode. This representative pixel was located near the
center of the AMFPD. The signals were obtained for a fixed frame time at
different bias voltages. The dark current can be obtained by dividing the
dark charge which is proportional to the dark signal by the frame time.
Strictly speaking, this is only valid as the frame time approaches zero. The
electric field is proportional to the bias voltage given that the thickness of
the photodiode pixel is constant. This graph shows that dark current in-
creases rapidly as the electric field increases.is Q1+Q2. The error reduces to Q1 if, for example, the
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relative to the charge originating from irradiation, reducing
the frame time cannot help to reduce the relative error. For-
tunately this is not the case. Although the shape of Idarkt
curve can vary due to variations in the dose delivery, it is
quite clear that Q2 is greater than Q1. If the dose rate at
the pixel is constant, the charge generated by the radiation in
the first half of a frame time equals that in the second half,
i.e., Qrad1Qrad2. Halving the frame time reduces the relative
error due to dark current since Q1 /Qrad1Q2 /Qrad2. Ac-
tually Qrad2 would be less than Qrad1 since the pixel sensitiv-
ity reduces as the electric field decreases, which further sup-
ports the above conclusion. In the region of Idarkt where t
→0, halving the frame time can reduce the relative error by
a factor of two because Q1+Q2 / Qrad1+Qrad2
2Q1 /Qrad1 as t→0. Given that frame times as long as
tens of seconds can be necessary in radiographic mode in
FIG. 3. Pixel dose response at different bias voltages. The AMFPD was
operated in fluoroscopic mode with a frame time of 1.2 s. 1010 cm2 open
fields were measured at 90 cm SSD and 10 cm depth in solid water phan-
tom. The AMFPD signals from the central 1010 pixels were averaged
and then plotted in this graph. The absolute dose values were measured with
an ion chamber in a water tank. The data were taken at a dose rate of 320
cGy/min for 6 MV photon beams. The linear correlation coefficient squared,
2
FIG. 2. A schematic graph showing dark current changes during irradiation.
The upper straight line is the dark current in the absence of radiation during
a time period Tframe corresponding to the frame time. The lower curve is the
dark current with radiation present. Q1 is the error introduced by subtract-
ing a constant dark charge during the first half of the frame time Tframe and
Q2 is that error during the second half of the frame time.r , for every response curve is greater than 0.999997.
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treatment, and given that larger frame times result in increas-
ingly less accurate dose estimation, it is advantageous to op-
erate the AMFPD in fluoroscopic mode using considerably
shorter frame times. In this manner, the total dose is spread
over many frames as opposed to a single frame in radio-
graphic mode. Therefore, the relative error due to constant
dark charge subtraction is significantly reduced.
The fastest frame time allowed by the present AMFPD is
1.2 s in fluoroscopic mode.10 In this interval, the dose re-
ceived in each frame is typically less than 10 cGy. Thus the
corresponding change in the electric field is generally much
smaller than that in the radiographic mode, leading to re-
duced variation in dark charge and better linearity in dose
response.
In the present study, a fluoroscopic acquisition sequence
used to measure a radiation field consisted of 30–100 ignored
frames at the beginning of the acquisition before the radia-
FIG. 4. Pixel sensitivity plotted as a function of bias voltage. The AMFPD
was operated in fluoroscopic mode with a frame time of 1.2 s. Several 10
10 cm2 open fields with various MUs were measured at bias voltages of
−1, −2, −4, −6, and −7 V. The signals from the central 1010 pixels were
averaged, and the average pixel sensitivity was obtained. The data were
taken at dose rates of 320 cGy/min and 80 cGy/min for 6 MV photon beams.
FIG. 5. Pixel sensitivity plotted as a function of dose rate. The AMFPD was
operated in fluoroscopic mode with a frame time of 1.2 s. Several 10
10 cm2 open fields with various MUs were measured at bias voltages of
−2 V and −4 V. The signals from the central 1010 pixels were aver-
aged, and the average pixel sensitivity was obtained. The data were taken at
dose rates of 80, 320, and 360 cGy/min for 6 MV and 16 MV photon beams.
4914 Chen et al.: Performance of AMFPD for IMRT dosimetry 4914tion begins 0.6–2 min, then 10–20 dark image frames fol-
lowed by the data image frames obtained during the irradia-
tion, and finally 20–30 image frames after the radiation stops
to measure the lag. Ignored frames are performed before
radiation is delivered in order to initialize the pixels to re-
move previously accumulated or trapped charge. The lag im-
age frames are acquired to ensure that trapped charge re-
leased after the irradiation is measured. The acquisition
electronics send a signal at the end of the dark image frames
to inform the operator to start radiation delivery. When an
acquisition sequence is finished, the average dark image
frame is determined and subtracted from each of the data and
lag image frames. Then the resulting net signal frames are
summed. Finally, bad pixels are corrected through interpola-
tion, and a pixel-by-pixel gain correction, obtained from a
flood field irradiation, is applied. In order to obtain a rela-
tively uniform field for the flood field, the AMFPD is placed
on or near the floor perpendicular to the gantry in the solid
water phantom at 10 cm depth. An algorithm is then used to
preserve the remaining shape of the open field dose distribu-
tion at that distance and depth.
II.C. Dose response linearity
Dose response, as indicated by pixel sensitivity, was mea-
sured with static 1010 cm2 fields at 10 cm depth and 90
cm source-to-surface distance SSD for 6 and 16 MV at
dose rates ranging from 100 to 600 MU/min in 100 MU/min
increments and at various Vbias values ranging from −1 to
−7 V. The 6 and 16 MV photon beams were calibrated such
that 1 MU delivers 0.8 cGy of dose for a 1010 cm2 jaw
field at 10 cm depth in water with 90 cm SSD. For a specific
bias voltage, beam energy, and dose rate, images were ac-
quired for different MU values, and an ion chamber point
measurement was taken under the same geometric and irra-
diation conditions to get the absolute dose. The measured
dose calibration curve was fit with a linear relation where the0, if Dc − Dr G
Medical Physics, Vol. 34, No. 12, December 2007slope yielded the pixel sensitivity, and absolute pixel dose
was obtained by multiplying the net pixel signal value and
the appropriate pixel sensitivity.
II.D. IMRT measurements
Measurements were performed using a Varian 21 EX ac-
celerator equipped with a 120 leaf multileaf collimator
Varian Medical Systems, Palo Alto, CA. The surface of the
detector array was placed at 3, 5, and 10 cm depths for dif-
ferent IMRT measurements. The same IMRT fields were
measured with XV or EDR2 film depending on the maxi-
mum field dose. A film characteristic curve was obtained for
each set of film measurements so that optical densities could
be converted to dose. Processor response was monitored for
a sampling of films using a sensitometer in each processing
session. Fiducials pinholes were used to mark the central
axes of the film for IMRT measurements. As described in
Sec. II C, AMFPD measurements were independently con-
verted to dose as well. Comparisons were made between the
two-dimensional dose distributions measured with the
AMFPD and with film.
The test cases shown in this article included prostate
SMLC IMRT fields with 0.50.5 cm2 beamlets, head and
neck SMLC IMRT fields with 11 cm2 beamlets, and high
dose per fraction partial breast IMRT fields with 0.5
0.5 cm2 or 11 cm2 beamlets sequenced and delivered
with SMLC or DMLC IMRT. A dose rate of 400 MU/min
320 cGy/min measured at 10 cm depth and 90 cm SSD in
water was used for all deliveries. Measurements were taken
at 5 cm depth unless otherwise specified.
II.E. Data evaluation
The dose distributions of individual fields were compared
for the AMFPD and film using isodose overlays, dose differ-
ence evaluation, and extraction of sample profiles across re-
gions of interest ROIs. Also, to quantify the agreement be-
tween the AMFPD and film, we calculated , , and dose-
gradient compensation C indices for all fields.11–13 The
definitions of these quantities are as follows:rr = min	
rc − rr2
rtol
2 +
Dc − Dr2
Dtol
2 for any rc , 1
rr =
Dc − Dr

Dtol2 + rtol2  Dr2
, 2
Crr =  Dc − DrDc − Dr  Dc − Dr − Gr rtolDtol , if Dc − Dr Gr rtol , 3
r rtol
radiographic acquisition mode in X and Y jaw directions.
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dose map, rc and rr are the corresponding locations, Dtol is
the tolerance dose difference, and rtol is the distance to
agreement DTA. G is defined as Gi=
 jDij /rij2,
where j loops around the nearest neighbors of i. G is ap-
proximately as large as 
2· D for a two-dimensional dose
map.
The tolerance dose for the dose difference calculation was
set to 2% of Dmax. The criteria of 2% of DmaxDtol and 2
mm DTA rtol i.e., 2% /2 mm were used to calculate the
 and  values. The  and C values for 2% /1 mm criteria
were also reported. To remove the bias on the level of agree-
ment for very low dose regions, the ROI was determined as
the area where the dose was higher than 5% of the maximum
dose. A satisfaction index is defined as the percentage of the
area within the ROI where certain criteria are satisfied over
the total area of the ROI:
Satisfaction index
=
# of pixels whose  1 and D 5%Dmax
# of pixels whose D 5%Dmax
,
4
where  can be replaced by  or C to get their respective
satisfaction indices.
III. RESULTS
III.A. Dose response linearity
Dose response is characterized by the pixel sensitivity.
The response in fluoroscopic mode with a 1.2 s frame time
was linear for all situations with correlation coefficient
squared r20.99999, as shown in Fig. 3. The highest dose
tested in the present study was 1040 cGy, and the linear
correlation coefficient square equals 0.999998 in this case.
However, the pixel sensitivity varies with bias voltage and
dose rate as shown in Figs. 4 and 5. Figure 4 shows that the
pixel sensitivity decreases faster as the reverse bias voltage is
reduced. Since the charge accumulated in the photodiode
gradually decreases the electric field, the effective bias volt-
age across it would also decrease. For this reason, pixel sen-
sitivity during the irradiation is not constant, leading to the
nonlinear response in radiographic mode in the high dose
region described in Sec. II B. Thus it is desirable to operate
the AMFPD at a higher bias voltage where the pixel sensi-
tivity decreases slowly as the electric field drops during irra-
diation.
For a fixed frame time in fluoroscopic mode, the pixel
sensitivity also decreases slightly as the dose rate increases
Fig. 5. As the dose rate increases, the charge accumulated
during one frame time increases, resulting in a slight de-
crease in the electric field across the photodiode, which in
turn results in the dose rate dependence of the fluoroscopic
mode. When compared with an ion chamber, measurements
with the AMFPD in fluoroscopic mode have shown a higher
increase in response with increasing field size. These differ-
ences can be corrected by deconvolving the raw signal with aFIG. 6. Dose response from a static 1010 cm2 field of 80 cGy obtained
with the AMFPD for a 6 MV photon beam at a bias voltage of −6 V. a 2D
dose response obtained in fluoroscopic mode with a frame time of 1.2 s. b
2D dose response in radiographic mode with a frame time of 17 s. c
Sample line profiles extracted from a and b comparing fluoroscopic andkernel to account for low-energy photons. Since film has a
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in this study for these effects to film or AMFPD data.
III.B. Effect of dark current
Static 1010 cm2 field images for 100 MU were taken
with the AMFPD at a Vbias of −6 V in both fluoroscopic and
radiographic mode. The effect of dark current was signifi-
cantly reduced in fluoroscopic mode compared with that in
radiographic mode as shown in Fig. 6. In this particular case,
the frame time of fluoroscopic mode was 1.2 s compared
with 17 s of radiographic mode. Clearly, the radiation profile
of the AMFPD in radiographic mode exhibits large discrep-
ancies as compared with the dose profile one would expect to
obtain from an ionization chamber measurement.
In fluoroscopic mode, static 1010 cm2 field images for
the same amount of dose were taken at different bias volt-
ages, as shown in Fig. 7. The change in the dark current still
had a detectable effect on the dose image, as explained in the
next paragraph, even though the effect was greatly reduced
in comparison with the effect with radiographic mode.
A dose-independent pixel gain correction is insufficient to
eliminate this effect because of the nonlinear relation be-
tween the dark current and the electric field. Ideally, the
charge originating from radiation can be obtained by sub-
tracting the dark charge from the total charge, i.e., Qrad=Q
−Qdark. The actual pixel sensitivity is s˜= Q−Qdark /D. How-
ever, the measured sensitivity is s= Q−Qdark 0 /D where
Qdark 0 is measured in the absence of radiation. This leads to
Medical Physics, Vol. 34, No. 12, December 2007a problem in the pixel gain correction. Each pixel has a
slightly different gain and dark current originating from the
manufacturing process and from channel-to-channel varia-
tions in the preamplifiers. If one takes a pixel No. 1 as the
reference pixel and a second pixel No. 2 is corrected rela-
tive to it, then the applied pixel gain correction can be ex-
pressed as s2= 1+	s1, although, ideally, it should be s˜2
= 1+
s˜1. Here 	 and 
 represent the small variation in pixel
sensitivity between the two photodiodes. Given that the ac-
tual pixel sensitivity, s˜, is independent of dose when dose is
small, 
 can be assumed dose independent. Therefore, the
gain would be corrected as long as the ratio 1+	 / 1+
 is
independent of dose. Since both 	 and 
 are small, the ratio
is approximately 1+	−
. It can readily be shown that
	 − 

Qdark,2 − Qdark,1 − Qdark 0,2 − Qdark 0,1
Q1 − Qdark,1
. 5
The quantity 	−
 may not be constant with respect to
dose since the quantity related to dark current, Qdark,2
−Qdark,1− Qdark 0,2−Qdark 0,1, is not, in general, linear with
dose. Although the pixel gain was corrected at a certain dose
per frame with a flood field, the difference between different
pixels in the corrected image could still be detectable at an-
other dose per frame due to changes in dark current. This is
a result of the dose-independent dark charge subtraction and
dose-independent pixel gain correction. However, the dark
current decreases much faster with a reduced bias voltage
FIG. 7. Dose response from a static
1010 cm2 field of 160 cGy obtained
with the AMFPD in fluoroscopic mode
with a frame time of 1.2 s for a 6 MV
photon beam at different bias voltages:
a −7 V, b −6 V, c −4 V, and d
−2 V. The plotted dose range is from
100 to 180 cGy.than the charge signal Q1−Qdark,1. Therefore, when the bias
4917 Chen et al.: Performance of AMFPD for IMRT dosimetry 4917voltage is low, the quantity related to dark charge is much
less than the charge generated by the radiation. Thus, the
impact of the change in the dark current is not as large as
when the bias voltage is high.
The above considerations provide motivation to operate
the AMFPD at a low bias voltage. However, as discussed in
Sec. III A, a consideration of the dependence of the pixel
sensitivity on the bias voltage favors a higher bias voltage.
Thus, a compromise must be made in choosing the optimal
bias voltage. We found that a bias voltage from −4 V to
−6 V was suitable for reliable dosimetry with a frame time
of 1.2 s. The bias voltage used in the following IMRT mea-
surements was −6 V prostate B1B7, H&N B1B9, PBI
B1B3, and −4 V remaining cases.
III.C. IMRT measurements
For illustration, the results for three sample fields are
shown in Figs. 8–10. For each field, isodose overlays, dose
difference plots, dose maps, and sample line profiles are
shown. Figure 8 shows a head and neck field H&N B1 in
Table I composed of 11 cm2 beamlets. It consists of two
FIG. 8. Results corresponding to head and neck case B1: a iso-dose overlay
plot in cGy AMFPD-film; c AMFPD dose map; and d sample line profi
For these results, and that shown in Figs. 9 and 10, the AMFPD was operasplit fields overlapping for 3 cm. The first field has 95 seg-
Medical Physics, Vol. 34, No. 12, December 2007ments, and the second field has 79 segments. The two images
were combined after the SMLC deliveries. Figure 9 shows a
partial breast field DMLC PBI 3cm in Table I with 1
1 cm2 beamlets. This field has 150 control points and was
delivered with DMLC. The AMFPD was placed at a 3 cm
depth for this field. Figure 10 shows a prostate field Prostate
B7 in Table I composed of 0.50.5 cm2 beamlets and
SMLC delivery consisting of 83 segments. Two line profiles
across the high dose region were extracted for each field.
As described in Sec. II E, the satisfaction indices of , ,
and C were calculated with various criteria, along with the
number of segments and the maximum dose for each field,
shown in Table I. Table II demonstrates the stability of the
AMFPD. When AMFPD measurements on different dates
were compared, nearly 100% of the ROI satisfies the
2% /2 mm criteria. When XV film measurements taken on
different dates were compared, the results showed similar
excellent consistency Table III, though agreement between
EDR2 and XV was much worse. The agreement between the
AMFPD and XV was only slightly worse than the demon-
obtained with AMFPD dashed line and film solid line; b dose difference
mparison between the AMFPD and film along the lines as indicated in c.
fluoroscopic mode with a frame time of 1.2 s.plot
le co
ted instrated XV consistency see the bottom row in Table III. As
4918 Chen et al.: Performance of AMFPD for IMRT dosimetry 4918noted in case 3 of Table III, the radiation field was delivered
twice for the EDR2 film in order to achieve an adequate
signal-to-noise ratio for the low dose field.
A series of XV film data in dose response H&D curve
measurements shows that the relative error  /mean due to
random noise is less than 0.7% at the isocenter for all the 19
fields with dose from 0 to 192 cGy. The difference between
dose measured with film and that with an ion chamber for the
same series of XV film data is 0.0±0.5 cGy.
IV. DISCUSSION
IV.A. Dose response linearity
As reported in our previous work,8 the dose response of
each pixel is not linear in radiographic mode, especially
when the dose is high. Clearly, the intrinsic nonlinear dose
response for a single frame time is due to the decrease in the
electric field across the photodiode as more and more charge
is accumulated and the pixel sensitivity is no longer a con-
stant.
The AMFPD demonstrates excellent linearity of the dose
FIG. 9. Results corresponding to DMLC PBI case at a depth of 3 cm: a iso
dose difference plot in cGy AMFPD-film; c AMFPD dose map; and d
indicated in c.response in fluoroscopic mode. This is because the dose de-
Medical Physics, Vol. 34, No. 12, December 2007livered to the AMFPD is divided into many frames by read-
out of the signal at a constant rate. Even though the dose
response might not be linear for a given fraction in a single
frame time, the overall response is still linear as long as the
frame time is much smaller than the total delivery time. Also,
the total amount of dose that can be delivered to a pixel is
limited only by the memory size of the control computer to
store all the frames. In this work, we found excellent linear-
ity for doses up to 1040 cGy.
The bias voltage dependence of the pixel sensitivity for
direct detection is different from that for indirect detection
with a scintillator screen.10 For indirect detection, the x rays
are converted into optical photons, and the absorption of
these optical photons happens closer to the p-doped layer
near the top of the photodiode. The signal transport mecha-
nism is dominated by the transit of electrons through the
intrinsic layer. Therefore, the charge collection efficiency
does not change much for a wide range of the bias voltage,
and thus the pixel sensitivity is almost constant.9,10 On the
other hand, for direct detection the x-ray interactions are
more uniformly distributed along the depth of the intrinsic
overlay plot obtained with AMFPD dashed line and film solid line; b
le line profile comparison between the AMFPD and film along the lines as-dose
sampa-Si:H bulk. Therefore, more electron-hole pairs are gener-
4919 Chen et al.: Performance of AMFPD for IMRT dosimetry 4919ated deeper in the intrinsic layer. In this case the signal trans-
port mechanism is a combination of the transit of electrons
and holes. Due to the much lower mobility of holes
10−3 cm2 /V s relative to that of electrons
1 cm2 /V s, the recombination probability may be
higher, and the charge collection may not be as effective as
in the case of indirect detection and the bias voltage depen-
dence would be stronger.
IV.B. Dark current and acquisition mode
considerations
As seen in Fig. 7, the level of dark current affects the dose
image quality, allowing better results at a lower bias voltage.
However, the bias voltage dependence of the pixel sensitivity
is less desirable for a lower bias voltage when the actual or
effective dose rate varies, as may occur when beam hold offs
are executed when delivering SMLC or DMLC fields.14 An-
other factor that affects the dose image quality is the signal
to noise ratio SNR. The dose response sensitivity is signifi-
FIG. 10. Results corresponding to prostate case B7 with 0.50.5 cm2 beam
line; b dose difference plot in cGy AMFPD-film; c AMFPD dose map
lines as indicated in c.cantly lower if a low bias voltage is applied, which also
Medical Physics, Vol. 34, No. 12, December 2007jeopardizes the dose image quality. Therefore, these trade-
offs must be considered when choosing an appropriate bias
voltage.
The dosimetric performance of the AMFPD can be im-
proved by a higher frame rate. A shorter frame time makes
the dose in each frame smaller. Hence, the dark charge and
pixel sensitivity become more constant. Also, artifacts from
the dose-independent pixel gain correction as well as dose
rate dependence will be reduced. As the dark charge de-
creases, the AMFPD can be operated at a higher bias voltage
to improve SNR. The initialization time for the ignored
frames can be eliminated for a system whose acquisition
electronics operate in a continuous readout mode whenever
the system is powered on.
IV.C. IMRT measurements
In general, we found excellent agreement between the
IMRT dose distributions of the AMFPD and that of both XV
and EDR2 film Table I. If 2% /2 mm is taken as the criteria
for agreement, on average, 97.5±1.9% of the region where
a iso-dose overlay plot obtained with AMFPD dashed line and film solid
d sample line profile comparison between the AMFPD and film along thelets: 
; andthe dose is greater than 5% of the maximum dose satisfies
4920 Chen et al.: Performance of AMFPD for IMRT dosimetry 49201. As expected, evaluation based on  gave almost the
same results as that based on . Since the AMFPD and film
were irradiated separately, variations in the delivery of the
radiation might also lead to small differences between the
dose distributions. The consistency of the AMFPD dose dis-
tributions for IMRT fields was verified by comparing dose
images obtained on different dates Table II. In this case,
99.9% of the region where dose is greater than 5% of maxi-
mum satisfies 1. This result is similar to that from com-
parisons of a single type of film and better than that from
comparisons between different film types Table III. This
suggests that the AMFPD can be a substitute for film in
IMRT dosimetry measurements since the discrepancy be-
tween different types of film is no less than that between an
TABLE I. Results of comparison of AMFPD and film
reported are the satisfaction indices using each of ,
at 5 cm depth for the first 19 fields. The last thre
respectively. The number of segments for SMLC or co
column.
Dmax 
Field criteria Segments cGy 2% /2 mm
Prostate B1 87 62 96.5%
Prostate B2 75 62 97.7%
Prostate B3 81 65 98.2%
Prostate B4 95 58 97.4%
Prostate B5 84 66 95.6%
Prostate B6 71 62 95.5%
Prostate B7 83 64 98.2%
H&N B1 95+79 67 97.7%
H&N B2 73 39 95.8%
H&N B3 94+48 56 99.1%
H&N B4 110+69 52 97.9%
H&N B5 101+88 63 92.4%
H&N B6 104+108 65 97.2%
H&N B7 74 48 98.3%
H&N B8 106+119 44 96.4%
H&N B9 94+80 53 98.3%
PBI B1 95 172 96.2%
PBI B2 87 198 94.9%
PBI B3 82 223 99.2%
H&N B10 10 cm 127+149 55 99.0%
DMLC PBI 10 cm 150 158 98.6%
DMLC PBI 3 cm 150 296 98.5%
Mean±std 97.2±1.7%
TABLE II. Comparisons of AMFPD measurements p
satisfaction indices using each of , , and C, for di
The number of segments in each field is listed in the
of the AMFPD.
Dmax 
Field criteria Segments cGy 2% /2 mm
PBI B2 87 197 99.9%
PBI B3 82 221 100.0%
H&N B1 95+79 67 100.0%
H&N B7 74 48 99.9%Medical Physics, Vol. 34, No. 12, December 2007AMFPD and film. For example, Dogan et al. also reported
discrepancies between EDR2 and XV2 films for IMRT
verification.15
In the present study, the few discrepancies between the
AMFPD and film measurements were primarily in regions
where high dose is delivered to a small area such as a single
beamlet. The region of single beamlet spikes is often prob-
lematic for comparisons, and more research will be needed to
determine which systems, analysis, or techniques are causing
the discrepancies.
The comparison between the AMFPD and film was made
for both SMLC and DMLC fields, with 0.50.5 cm2 and
11 cm2 beamlets, at different depths. These results show
that the AMFPD is capable of IMRT QA verification as a
urements made for 22 fields in this study. The values
d C, for different criteria. Measurements were taken
ds were measured at depths of 10, 10, and 3 cm,
points for DMLC in each field is listed in the second
 C
% /0 mm 2% /1 mm 2% /2 mm 2% /1 mm
69.1% 91.4% 96.8% 98.1%
74.4% 94.8% 98.1% 99.2%
83.1% 96.8% 98.6% 99.5%
69.6% 95.6% 98.8% 99.5%
66.8% 89.4% 95.9% 98.2%
75.9% 93.1% 96.5% 98.0%
85.4% 98.0% 99.3% 99.9%
81.3% 94.4% 97.5% 99.1%
76.2% 90.3% 94.6% 98.1%
94.8% 98.9% 99.4% 99.8%
86.8% 96.0% 98.1% 99.5%
71.1% 86.7% 92.3% 95.4%
86.3% 94.9% 97.0% 98.8%
86.9% 96.3% 98.4% 99.6%
76.9% 91.2% 96.6% 98.6%
87.8% 96.3% 98.2% 99.5%
74.2% 91.6% 96.5% 98.6%
73.1% 99.8% 94.9% 98.0%
91.4% 98.3% 99.4% 100.0%
85.0% 96.6% 99.0% 99.8%
84.3% 99.3% 100.0% 100.0%
93.1% 100.0% 100.0% 100.0%
.6±8.2% 94.5±3.7% 97.5±1.9% 98.9±1.1%
ed on different dates. The values reported are the
t criteria. Measurements were taken at 5 cm depth.
d column. This comparison indicates the consistency
 C
/0 mm 2% /1 mm 2% /2 mm 2% /1 mm
7.9% 99.8% 99.9% 100.0%
9.4% 100.0% 100.0% 100.0%
9.4% 99.9% 100.0% 100.0%
8.5% 99.7% 99.8% 100.0%meas
, an
e fiel
ntrol
2
80erform
fferen
secon
2%
9
9
9
9
4921 Chen et al.: Performance of AMFPD for IMRT dosimetry 4921substitute for film measurements. This system maintains ex-
cellent uniform spatial resolution 0.508 mm over the entire
field up to 2626 cm2, compared with the typically non-
uniform resolution ranging from several millimeters to sev-
eral centimeters for available diode and ionization chamber
array systems.2,3
IV.D. Comparison to other verification systems
Although the AMFPD system is based on the same type
of a-Si:H detector plate used within commercial EPID sys-
tems, there are a number of significant differences between
IMRT dosimetry measurements made with the AMFPD sys-
tem and IMRT verification methods based on commercial
EPIDs. First, the AMFPD system is used in a solid water
phantom so it implements dosimetry measurements in phan-
tom, as most radiotherapy dosimetry is performed. For
EPID-based IMRT field verification, investigators have de-
veloped algorithms to reconstruct the delivered fluence map
from the portal image measured in the EPID.4,6,16 This recon-
structed fluence map can then be calculationally convolved
with a dose kernel to yield the expected two-dimensional
dose distribution in water, or it can be applied to the patient
geometry to calculate the three-dimensional dose distribution
in the patient. For example, one algorithm utilizes the mea-
sured dose response kernel of the detector to calculate the
portal dose in the detector given the intended fluence map.5
The calculated portal dose is then compared with the mea-
sured one. Another algorithm takes advantage of the sym-
metric geometry of the virtual phantom to derive the dose
distribution in that phantom from the fluence-related portal
image.17 All of these verification methods combine the out-
put from the portal image i.e., portal dose, detector dose
response kernel, or reconstructed fluence with an algorithm
that always involves the use of treatment planning-like cal-
culational information and/or methods from the treatment
planning system or an independent source of planning
system-like information. This calculated result may be par-
tially or totally independent of the clinical treatment plan-
ning system, but it is always based on a calculational method
and is not a direct measurement of the dose distribution that
has been delivered. Because the AMFPD system directly
measures the dose in phantom, the AMFPD-based verifica-
tion method is a much more robust and independent check
on IMRT delivery than can be achieved with an EPID-based
TABLE III. Comparisons of film measurements perfor
film case 2. The values reported are the satisfaction
Measurements were taken at 10 cm depth for the sam
number of segments in each field is listed in the sec
Dmax 
Case criteria Segments cGy 2% /2 mm
1: xv-xv 127+149 55 99.7%
2: edr-xv 127+149 55 91.6%
3: AMFPD-xv 127+149 55 99.0%system.
Medical Physics, Vol. 34, No. 12, December 2007V. CONCLUSIONS
The results reported in this article suggest that AMFPDs
could serve as excellent electronic dosimeters for IMRT and
could be used to replace film for phantom measurements.
When operated in continuous fluoroscopic acquisition mode,
the AMFPD characterized in this study maintained an excel-
lent linear dose response up to 1040 cGy over the six month
period of the study. In order to obtain reliable integrated dose
results for IMRT fields, the effects of the dark current on the
radiation signal were minimized. Compared with film, the
AMFPD results were excellent, generally within
2% / ±2 mm. Compared with other electronic devices, the
AMFPD has much higher spatial resolution 0.508 mm
across the entire measurement area of 2626 cm2 and pro-
vides high quality two-dimensional dosimetric measurements
for IMRT delivery characterization and verification.
ACKNOWLEDGMENTS
We would like to thank Joann I. Prisciandaro and Sue
Henshaw for providing some IMRT film data. The work was
supported in part by NCI P01 CA59827 and the University
of Michigan Cancer Center.
aAuthor to whom correspondence should be addressed; Electronic mail:
ychen7@gmail.com
1J. M. Galvin, G. Ezzell, A. Eisbrauch, C. Yu, B. Butler, Y. Xiao, I. Rosen,
J. Rosenman, M. Sharpe, L. Xing, P. Xia, T. Lomax, D. A. Low, and J.
Palta, “Implementing IMRT in clinical practice: a joint document of the
American society for therapeutic radiology and oncology and the Ameri-
can Association of Physicists in Medicine,” Int. J. Radiat. Oncol. Biol.
Phys. 58, 1616–1634 2004.
2D. Létourneau, M. Gulam, D. Yan, M. Oldham, and J. W. Wong, “Evalu-
ation of a 2D diode array for IMRT quality assurance,” Radiother. Oncol.
70, 199–206 2004.
3E. Spezi, A. L. Angelini, F. Romani, and A. Ferri, “Characterization of a
2D ion chamber array for the verification of radiotherapy treatments,”
Phys. Med. Biol. 50, 3361–3373 2005.
4B. B. Warkentin, S. Steciw, S. Rathee, and B. G. Fallone, “Dosimetric
IMRT verification with a flat-panel EPID,” Med. Phys. 30, 3143–3155
2003.
5A. Van Esch, T. Depuydt, and D. P. Huyskens, “The use of an aSi-based
EPID for routine absolute dosimetric pre-treatment verification of dy-
namic IMRT fields,” Radiother. Oncol. 71, 223–234 2004.
6M. Wendling, R. J. W. Louwe, L. N. McDermott, J. Sonke, M. van Herk,
and B. J. Mijnheer, “Accurate two-dimensional IMRT verification using a
back-projection EPID dosimetry method,” Med. Phys. 33, 259–273
2006.
7Y. El-Mohri, L. E. Antonuk, J. Yorkston, K.-W. Jee, M. Maolinbay, K. L.
Lam, and J. H. Siewerdsen, “Relative dosimetry using active matrix flat-
panel imager AMFPD technology,” Med. Phys. 26, 1530–1541 1999.
8
on different dates case 1 or with different types of
ces using each of , , and C, for different criteria.
ld of a head and neck case H&N B10 10 cm. The
olumn.
 C
/0 mm 2% /1 mm 2% /2 mm 2% /1 mm
6.6% 100.0% 100.0% 100.0%
7.6% 82.1% 90.0% 95.8%
5.0% 96.6% 99.0% 99.8%med
indi
e fie
ond c
2%
9
6
8J. M. Moran, D. A. Roberts, T. S. Nurushev, L. E. Antonuk, Y. El-Mohri,
4922 Chen et al.: Performance of AMFPD for IMRT dosimetry 4922and B. A. Fraass, “An Active Matrix Flat Panel Dosimeter AMFPD for
in-phantom dosimetric measurements,” Med. Phys. 32, 466–472 2005.
9L. E. Antonuk, Y. El-Mohri, W. Huang, K. Jee, J. H. Siewerdsen, M.
Maolinbay, V. E. Scarpine, H. Sandler, and J. Yorkston, “Initial perfor-
mance evaluation of an indirect-detection, active matrix flat-panel imager
AMFPI prototype for megavoltage imaging,” Int. J. Radiat. Oncol. Biol.
Phys. 42, 437–452 1998.
10L. E. Antonuk, Y. El-Mohri, J. H. Siewerdsen, J. Yorkston, W. Huang, and
V. E. Scarpine, “Empirical investigation of the signal performance of a
high-resolution, indirect detection, active matrix flat-panel imager AM-
FPI for fluoroscopic and radiographic operation,” Med. Phys. 24, 51–70
1997.
11D. A. Low, W. B. Harms, S. Mutic, and J. A. Purdy, “A technique for the
quantitative evaluation of dose distributions,” Med. Phys. 25, 656–661
1998.
12A. Bakai, M. Alber, and F. Nűsslin, “A revision of the -evaluation con-Medical Physics, Vol. 34, No. 12, December 2007cept for the comparison of dose distributions,” Phys. Med. Biol. 48,
3543–3553 2003.
13J. M. Moran, J. Radawski, and B. A. Fraass, “A dose-gradient analysis
tool for IMRT QA,” J. Appl. Clin. Med. Phys. 6, 62–73 2005.
14D. Litzenberg, J. M. Moran, and B. A. Fraass, “Incorporation of realistic
delivery limitations into dynamic MLC treatment delivery,” Med. Phys.
29, 810–820 2002.
15N. Dogan, L. B. Leybovich, and A. Sethi, “Comparative evaluation of
Kodak EDR2 and XV2 films for verification of intensity modulated ra-
diation therapy,” Phys. Med. Biol. 47, 4121–4130 2002.
16S. Steciw, B. Warkentin, S. Rathee, and B. G. Fallone, “Three-
dimentional IMRT verification with a flat-panel EPID,” Med. Phys. 32,
600–612 2005.
17W. Ansbacher, “Three-dimensional portal image-based dose reconstruc-
tion in a virtual phantom for rapid evaluation of IMRT plans,” Med. Phys.
33, 3369–3382 2006.
